Introduction 82
Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the 83 gastrointestinal tract. Inflammation is associated with intestinal ulceration in both ulcerative 84 colitis (UC) and Crohn's disease (CD) . Bleeding and malabsorption may also occur in IBD 1, 2 , 85 and iron deficiency anaemia occurs in one-third of patients 1, 3 . The best way to administer iron 86 replacement to patients with IBD is a subject of debate, with both oral iron and intravenous 87 (IV) iron supplements being considered effective 4, 5 . However, ferrous forms of oral iron 88 replacement appear to be poorly absorbed, and the resultant free luminal iron likely results in 89 enhanced catalytic activity and production of reactive oxygen species within the intestine 6, 7 .
90
High dose oral iron consumption appears to be associated with more side effects than half of 91 the standard dose of iron 8 , perhaps as a result of unabsorbed iron reaching the colon.
92
Intravenous (IV) iron therapy offers effective alternative management of iron deficiency 93 anaemia. While the route of administration is not thought to influence disease activity; oral iron 94 supplements have been shown to disturb the microbiota, with disturbances in bacterial 95 phylotypes and associated aberrations in faecal metabolites compared with IV treatment 9, 10 .
97
The gut microbiota typically comprises greater than 10 11 microorganisms per gram of intestinal 98 content 11 , playing an important role in the maintenance of gut health, including protection 99 against pathogens (colonisation resistance) and the synthesis of beneficial short-chain fatty 100 acids (SCFA) generated through fermentation of dietary fibre 12, 13 . IBD is associated with a 101 perturbation of gut microbiota ('dysbiosis'), with the observed reduction in microbial diversity,
102
including a decline in beneficial bacteria from the phyla Bacteroidetes and Firmicutes, although 103 within these classifications a much more complicated picture exists, alongside enhancement 104 of some potentially harmful Proteobacteria, particularly within the family Enterobacteriaceae 105 14, 15 . The key mechanisms responsible for the development of this dysbiosis and its 106 contribution to IBD are to date poorly defined.
108
Iron is an essential metal that is required by most organisms 16 . It is a growth-limiting nutrient 109 for many gut bacteria, which compete for unabsorbed dietary iron in the colon 17 control groups and six DSS-treated groups were maintained either for 8 days or up to 10 days.
171
Three additional control groups of mice (to compare the effects of diets alone) received 172 drinking water without DSS, but with varying amounts of dietary iron for a total of 10 days, 173 under conditions as described above (see Table 1 ). Research at the University of Liverpool to generate the 16S Metagenomic Sequencing Library.
224
Primers described by Caporaso et al. 25 were used to amplify the V4 region of 16S rRNA; F: 
229
Approximately 5 µL of extracted DNA was used for first round PCR with conditions of 20 sec 230 at 95°C, 15 secs at 65°C, 30 sec at 70°C for 10 cycles then a 5 min final extension at 72°C.
231
Amplicons were purified with Axygen SPRI Beads before a second-round PCR was performed 232 to incorporate Illumina sequencing adapter sequences containing indexes (i5 and i7) for 233 sample identification as described in 25 . Fifteen cycles of DNA amplification by PCR were 234 performed using the same conditions as above, i.e., 25 cycles overall. Again, samples were 235 purified using Axygen SPRI Beads before being quantified using Qubit and assessed using 236 the Fragment Analyser. Successfully generated amplicon libraries were used for sequencing.
238
The final libraries were pooled in equimolar amounts using the Qubit and Fragment Analyser, of the amplicon library, 15% PhiX was spiked as described by Altschul et al. 27 .
245

Bioinformatics analysis 246
Initial processing and quality assessment of the sequence data was performed using an in-247 house pipeline. Base calling and de-multiplexing of indexed reads were conducted by 248 CASAVA version 1.8.2 (Illumina) as described by Schubert et al. 28 . The raw fastq files were 249 trimmed to remove Illumina adapter sequences with any reads matching the adapter sequence 250 over at least 3 bp being trimmed off. The reads were further trimmed to remove low-quality 251 bases (reads <10 bp were removed). Read pairs were aligned to produce a single sequence 252 for each read pair that would entirely span the amplicon. Sequences with lengths outside of 253 the expected range (which are likely to represent errors) were also excluded. Sequences 254 passing the above filters for each sample were pooled into a single file. A metadata file was 255 created to describe each sample. These two files were used for metagenomics analysis using 256 Qiime, version 1.8.0 as described by Caporaso et al. 29 . Similar sequences were clustered into 257 groups, to define OTUs of 97% similarity. OTU-picking was performed using USEARCH7 as 258 described by Edgar et al. 30 
328
Faecal calprotectin concentration data were normalised to the values found in control samples 329 with higher levels seen in the mice on modified (half and double of the standard content) iron 330 diet compared to those fed the standard 200 ppm iron diet (Fig 4) . This finding was seen at 332 40 ± 1.12% and 80 ± 1.08% increase for the half of the standard, standard and the double of 333 the standard iron diets, respectively). The maximal faecal calprotectin levels were seen at day- 
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Analysis of alpha-diversity (statistical significance of Shannon) indicated that there was a 377 significant reduction in species richness in faecal samples taken from the 400 ppm iron fed,
378
the DSS-treated group between day-1 and day-10 (P<0.0066; Shannon diversity index) ( Fig   379  6-a) . To assess whether the differences in species richness were attributable to alterations in 380 the relative abundance of specific bacterial groups, we compared the proportions of various 381 taxonomic groups at the phylum level. Bacteroidetes was the most abundant phyla present, 382 followed by Firmicutes, Cyanobacteria and Proteobacteria (Table 2) . Phyla changes were 383 seen in all DSS-treated groups when day-10 samples were compared to day-1. However,
384
these changes were only observed to be statistically significant for the mice consuming 400 386 fold) and Actinobacteria (1.30 ± 0.1-fold increase) and concomitant reductions in Firmicutes 387 (0.6 ± 0.1-fold) and Bacteroidetes (0.8 ± 0.04-fold); these changes have been explicitly 388 accredited to Proteobacteria, Actinobacteria, Firmicutes and Bacteroidetes, which occurred in 389 the presence of inflamed versus non-inflamed tissues even within the same group. Therefore, 390 the double of the standard iron diet group had the highest relative abundance among inflamed 391 (colitis) groups on the subject of reduction or increase changes (day-1 vs day-10) ( Table 2   392 and Fig 6-b) .
393
394 
408
We searched for differences between day-1 and day-10 samples by considering delta-values 409 calculated as differences in sequence abundances (before and after treatment). No, 410 statistically significant changes were observed in mice receiving diets containing half of the 411 standard iron levels where DSS was administered, despite showing similar trends to those 412 mice on double the standard diet iron levels (Fig 7) . 
423
Principal Component Analysis (PCA) was used to identify linear combinations of gut microbial 424 taxa that were associated with specific diets. There was a clear separation of samples from 425 the mice consuming a chow diet containing 400 ppm before (day-1) and after (day-10) DSS-426 treatment which was not seen in the other treatment groups (Fig 8) . This suggests that DSS-427 induced colitis, in the presence of double the standard level of dietary iron intake, affected the 428 bacterial community significantly more than that observed in all other diet groups (P<0.0066;
429
Shannon diversity index) (Fig 6-a) . 400 ppm) (b, c, and d respectively) 
472
Specifically, the severity of colitis appeared to positively associate with the amount of iron 473 consumed. However, they did not investigate the effects of consumption of lower than normal 474 amounts of iron in their work 32 . A study by Erichsen et al. 33 reported that the addition of low- 
490
For humans, faecal calprotectin measurement is commonly used as an assessment tool for 491 disease activity in IBD 34, 35 . We, therefore, used this additional approach and measured 492 murine faecal calprotectin levels to examine whether dietary iron levels affected inflammation.
493
The degree of colonic inflammation was found to be significantly higher for DSS-treated mice 494 receiving 400 ppm iron in their chow as assessed by faecal calprotectin concentration. The
495
histopathological changes observed were consistent with the faecal calprotectin levels 496 measured, which were higher at day-8 than at day-10, particularly in the high-and low-iron 497 fed, DSS-treated groups. A previous study in African infants by Jaeggi and colleagues 36 also 498 noted that oral iron supplementation was associated with increased concentrations of faecal 
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This is the first study to use models of colitis to contemporaneously assess the influence of 579 dietary iron content on both disease activity and the microbiome. It emphasises the detrimental 580 effects of both halving and doubling the amount of iron in the diet on a murine model of IBD.
581
The diet with double the standard level of iron (400 ppm) led to key changes in the microbiome 582 and this would imply that these changes observed were not simply driven by the severity of 583 inflammation, but rather that lumenal free iron can also contribute to the complex interaction 584 of factors that lead to the development of a dysbiotic state as has frequently been observed 585 in IBD. There is more to understand how all sources of luminal iron influence IBD.
586
Furthermore, work is needed to outline the physiological impact on the gut microbiota resultant 587 from increased availability of luminal iron and how this may affect bacterial phyla and diversity.
588
Future intervention studies in humans will be invaluable to further define the complex effects 589 of different doses of therapeutic oral iron on the human gut microbiota, particularly to 590 understand the metabolic consequences of observed phyla changes.
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